Insider Selling: Astera Labs (NASDAQ:ALAB) Director Sells 10,000 Shares of Stock

Astera Labs, Inc. (NASDAQ:ALAB) Director Jack Lazar sold 10,000 shares of the stock in a transaction on Thursday, June 4th. The shares were sold at an average price of $355.17, for a total value of $3,551,700.00. Following the sale, the director directly owned 75,688 shares in the company, valued at $26,882,106.96. This trade represents a 11.67% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Astera Labs Price Performance

Shares of Astera Labs stock traded up $29.27 during trading on Monday, hitting $346.33. 5,034,882 shares of the company’s stock traded hands, compared to its average volume of 5,971,726. Astera Labs, Inc. has a 1 year low of $84.78 and a 1 year high of $372.37. The stock has a market capitalization of $59.36 billion, a P/E ratio of 234.01, a PEG ratio of 4.20 and a beta of 3.94. The business has a 50-day simple moving average of $217.60 and a 200-day simple moving average of $173.27.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings data on Tuesday, May 5th. The company reported $0.61 EPS for the quarter, beating the consensus estimate of $0.54 by $0.07. Astera Labs had a return on equity of 18.49% and a net margin of 26.72%.The company had revenue of $308.36 million for the quarter, compared to analysts’ expectations of $292.19 million. During the same period last year, the firm posted $0.33 earnings per share. Astera Labs’s revenue was up 93.5% compared to the same quarter last year. Astera Labs has set its Q2 2026 guidance at 0.680-0.700 EPS. On average, equities analysts predict that Astera Labs, Inc. will post 1.84 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently bought and sold shares of ALAB. Glenmede Trust Co. NA increased its stake in Astera Labs by 2.7% in the 1st quarter. Glenmede Trust Co. NA now owns 1,909 shares of the company’s stock worth $209,000 after acquiring an additional 51 shares during the last quarter. Lido Advisors LLC increased its stake in Astera Labs by 0.5% in the 4th quarter. Lido Advisors LLC now owns 12,297 shares of the company’s stock worth $2,046,000 after acquiring an additional 57 shares during the last quarter. Perigon Wealth Management LLC increased its stake in Astera Labs by 6.2% in the 4th quarter. Perigon Wealth Management LLC now owns 1,252 shares of the company’s stock worth $208,000 after acquiring an additional 73 shares during the last quarter. Clearstead Advisors LLC increased its stake in Astera Labs by 13.6% in the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the last quarter. Finally, Sound Income Strategies LLC increased its stake in Astera Labs by 9.2% in the 4th quarter. Sound Income Strategies LLC now owns 902 shares of the company’s stock worth $164,000 after acquiring an additional 76 shares during the last quarter. 60.47% of the stock is owned by hedge funds and other institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ALAB shares. Susquehanna increased their price objective on Astera Labs from $155.00 to $230.00 and gave the company a “neutral” rating in a research report on Wednesday, May 6th. Royal Bank Of Canada increased their price objective on Astera Labs from $250.00 to $270.00 and gave the company an “outperform” rating in a research report on Wednesday, May 6th. Morgan Stanley increased their price objective on Astera Labs from $210.00 to $240.00 and gave the company an “overweight” rating in a research report on Wednesday, May 6th. UBS Group initiated coverage on Astera Labs in a research report on Tuesday, April 21st. They set a “neutral” rating and a $180.00 price objective on the stock. Finally, Roth Mkm reissued a “buy” rating and issued a $275.00 target price on shares of Astera Labs in a research report on Wednesday, May 6th. Twelve investment analysts have rated the stock with a Buy rating and eleven have issued a Hold rating to the stock. Based on data from MarketBeat.com, Astera Labs has an average rating of “Moderate Buy” and a consensus target price of $233.75.

Astera Labs Company Profile

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.